Search

everythinglearnresearchcommunity

for

Search:↓

Disease-specific tools better assess quality of life in alopecia areata patients.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Understanding patients' views on their illness can help improve their disease management.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

There is a significant need for better-validated quality of life tools in dermatology.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

The study created a 27-item measure to assess the impact of skin diseases.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

WAA-QOL measures impact of hair loss on women's well-being.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Both EQ-5D-5L and SF-6DV2 are valid for measuring health but can't be used interchangeably.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Female pattern hair loss greatly lowers quality of life, especially in young women.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.